India, June 26 -- Genomic Valley Biotech Limited said in a filing to BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, July 06, 2019, inter alia, to consider and approve the following decisions at the Corporate Office of the Company at G-74 Pushkar Enclave, Paschim Vihar, Delhi – 110063 at 11:45 A.M, to recommend, to the shareholders for their approval in ensuing Annual General Meeting, the Re-appointment of Parual Agrawal, Director of the Company, who is liable to retire by rotation and offer herself for re-appointment.
To appoint M/S ANDROS & CO., Chartered Accountants, Delhi as Statutory Auditors of the Company, in place of M/s. A.K. KHATTAR & Associates, Chartered Accountants, Delh...